WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996002252) USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/002252    International Application No.:    PCT/EP1995/002598
Publication Date: 01.02.1996 International Filing Date: 05.07.1995
Chapter 2 Demand Filed:    12.12.1995    
IPC:
A61K 31/505 (2006.01), A61K 31/52 (2006.01), A61K 31/70 (2006.01), C07H 19/00 (2006.01), C07H 19/167 (2006.01)
Applicants: KNOLL AKTIENGESELLSCHAFT [DE/DE]; Knollstrasse, D-67061 Ludwigshafen (DE) (For All Designated States Except US).
SZABO, Laszlo [DE/DE]; (DE) (For US Only)
Inventors: SZABO, Laszlo; (DE)
Agent: KARAU, Wolfgang; BASF Aktiengesellschaft, D-67056 Ludwigshafen (DE)
Priority Data:
P 44 25 280.3 16.07.1994 DE
Title (DE) VERWENDUNG VON (S)-ADENOSYL-L-METHIONIN (SAMe) UND DESSEN PHYSIOLOGISCH VERTRÄGLICHEN SALZEN ZUR BEHANDLUNG VON REPERFUSIONSSCHÄDEN, DIE DURCH TEMPORÄRE FOKALE ISCHÄMIE AUSGELÖST WERDEN
(EN) USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA
(FR) UTILISATION DE (S)-ADENOSYL-L-METHIONINE (SAMe) ET SES SELS PHYSIOLOGIQUEMENT COMPATIBLES POUR LE TRAITEMENT DE DOMMAGES DE REPERFUSION PROVOQUES PAR ISCHEMIE FOCALE TEMPORAIRE
Abstract: front page image
(DE)Es wird die Verwendung von (SAMe) und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die durch temporäre fokale Ischämie ausgelöst werden, beschrieben.
(EN)The invention concerns the use of SAMe and its physiologically compatible salts for treating reperfusion damage triggered by temporary focal ischaemia.
(FR)L'invention concerne l'utilisation de (S)-adénosyl-L-méthionine (SAMe) et de ses sels physiologiquement compatibles, pour le traitement de dommages de reperfusion provoqués par ischémie focale temporaire.
Designated States: AU, BG, BR, BY, CA, CN, CZ, FI, HU, JP, KR, KZ, MX, NO, NZ, PL, RU, SG, SI, SK, UA, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: German (DE)
Filing Language: German (DE)